Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 7Completed 7Terminated 4Active not recruiting 3Unknown 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2

Conditions

Melanoma 13Carcinoma, Non-Small-Cell Lung 6Neoplasms 4Uveal Melanoma 3Prostatic Neoplasms 3Sarcoma 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Brain Neoplasms 2Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous-Cell Lung Cancer 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Prostatic Diseases 1Osteosarcoma 1Neoplastic Cells, Circulating 1Neoplasms, Unknown Primary 1Neoplasms by Site 1Nasopharyngeal Carcinoma 1Metastatic Microsatellite Stable Colorectal Cancer 1Kidney Neoplasms 1Hypoxia 1Head and Neck Neoplasms 1Genital Neoplasms, Male 1

Interventions

Radiosurgery 12Temozolomide 10Radiotherapy 10Magnetic Resonance Spectroscopy 7Erlotinib Hydrochloride 6Bevacizumab 6Surgical Procedures, Operative 5Pemetrexed 5Gefitinib 5Drug Therapy 5Carboplatin 5pyrotinib 4icotinib 4aumolertinib 4Trastuzumab 3Spermine Synthase 3Radiation 3Lomustine 3Etoposide 3Dexmedetomidine 3Chlorotoxin 3Carmustine 3osimertinib 2camrelizumab 2apatinib 2Tyrosine Kinase Inhibitors 2Thiotepa 2Surveys and Questionnaires 2Sevoflurane 2Propofol 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Brain Neoplasms × Ipilimumab × Clear all
NCT03458455 2023-11-01

TREATMENT

Oslo University Hospital

Unknown
200 enrolled
CNS

Brain Neoplasms

NCT02460068 2015-06-02

NIBIT-M2

Italian Network for Tumor Biotherapy Foundation

Phase 3 Unknown
168 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡